104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector. LRB104 08649 BDA 18702 b A BILL FOR 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new 410 ILCS 27/5 410 ILCS 27/10 410 ILCS 27/25 new 745 ILCS 49/66 new Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector. LRB104 08649 BDA 18702 b LRB104 08649 BDA 18702 b A BILL FOR
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED:
410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new 410 ILCS 27/5 410 ILCS 27/10 410 ILCS 27/25 new 745 ILCS 49/66 new
410 ILCS 27/5
410 ILCS 27/10
410 ILCS 27/25 new
745 ILCS 49/66 new
Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector.
LRB104 08649 BDA 18702 b LRB104 08649 BDA 18702 b
LRB104 08649 BDA 18702 b
A BILL FOR
HB2462LRB104 08649 BDA 18702 b HB2462 LRB104 08649 BDA 18702 b
HB2462 LRB104 08649 BDA 18702 b
1 AN ACT concerning health.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Epinephrine Injector Act is amended by
5 changing Sections 5 and 10 and by adding Section 25 as follows:
6 (410 ILCS 27/5)
7 Sec. 5. Definitions. As used in this Act:
8 "Administer" means to directly apply an epinephrine
9 injector to the body of an individual.
10 "Authorized entity" means any entity or organization,
11 other than a school covered under Section 22-30 of the School
12 Code, in connection with or at which allergens capable of
13 causing anaphylaxis may be present, including, but not limited
14 to, independent contractors who provide student transportation
15 to schools, recreation camps, colleges and universities, day
16 care facilities, youth sports leagues, amusement parks,
17 restaurants, sports arenas, and places of employment. The
18 Department shall, by rule, determine what constitutes a day
19 care facility under this definition.
20 "Authorized individual" means an individual who has
21 successfully completed the training program under Section 10
22 of this Act.
23 "Department" means the Department of Public Health.
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB2462 Introduced , by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED:
410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new 410 ILCS 27/5 410 ILCS 27/10 410 ILCS 27/25 new 745 ILCS 49/66 new
410 ILCS 27/5
410 ILCS 27/10
410 ILCS 27/25 new
745 ILCS 49/66 new
Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector.
LRB104 08649 BDA 18702 b LRB104 08649 BDA 18702 b
LRB104 08649 BDA 18702 b
A BILL FOR
410 ILCS 27/5
410 ILCS 27/10
410 ILCS 27/25 new
745 ILCS 49/66 new
LRB104 08649 BDA 18702 b
HB2462 LRB104 08649 BDA 18702 b
HB2462- 2 -LRB104 08649 BDA 18702 b HB2462 - 2 - LRB104 08649 BDA 18702 b
HB2462 - 2 - LRB104 08649 BDA 18702 b
1 "Epinephrine injector" includes an auto-injector approved
2 by the United States Food and Drug Administration for the
3 administration of epinephrine and a pre-filled syringe
4 approved by the United States Food and Drug Administration and
5 used for the administration of epinephrine that contains a
6 pre-measured dose of epinephrine that is equivalent to the
7 dosages used in an auto-injector.
8 "Health care practitioner" means a physician licensed to
9 practice medicine in all its branches under the Medical
10 Practice Act of 1987, a physician assistant under the
11 Physician Assistant Practice Act of 1987 with prescriptive
12 authority, or an advanced practice registered nurse with
13 prescribing authority under Article 65 of the Nurse Practice
14 Act.
15 "Pharmacist" has the meaning given to that term under
16 subsection (k-5) of Section 3 of the Pharmacy Practice Act.
17 "Undesignated epinephrine injector" means an epinephrine
18 injector prescribed in the name of an authorized entity.
19 (Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18;
20 100-799, eff. 1-1-19.)
21 (410 ILCS 27/10)
22 Sec. 10. Prescription to authorized entity; use; training.
23 (a) A health care practitioner may prescribe epinephrine
24 injectors in the name of an authorized entity for use in
25 accordance with this Act, and pharmacists and health care
HB2462 - 2 - LRB104 08649 BDA 18702 b
HB2462- 3 -LRB104 08649 BDA 18702 b HB2462 - 3 - LRB104 08649 BDA 18702 b
HB2462 - 3 - LRB104 08649 BDA 18702 b
1 practitioners may dispense epinephrine injectors pursuant to a
2 prescription issued in the name of an authorized entity. Such
3 prescriptions shall be valid for a period of 2 years.
4 (b) An authorized entity may acquire and stock a supply of
5 undesignated epinephrine injectors pursuant to a prescription
6 issued under subsection (a) of this Section. Such undesignated
7 epinephrine injectors shall be stored in a location readily
8 accessible in an emergency and in accordance with the
9 instructions for use of the epinephrine injectors. The
10 Department may establish any additional requirements an
11 authorized entity must follow under this Act.
12 (c) An employee or agent of an authorized entity who is an
13 authorized individual or any other other individual who is an
14 authorized individual has completed training under subsection
15 (d) of this Section may:
16 (1) provide an epinephrine injector to any individual
17 on the property of the authorized entity whom the
18 employee, agent, or other individual believes in good
19 faith is experiencing anaphylaxis, or to the parent,
20 guardian, or caregiver of such individual, for immediate
21 administration, regardless of whether the individual has a
22 prescription for an epinephrine injector or has previously
23 been diagnosed with an allergy; or
24 (2) administer an epinephrine injector to any
25 individual on the property of the authorized entity whom
26 the employee, agent, or other individual believes in good
HB2462 - 3 - LRB104 08649 BDA 18702 b
HB2462- 4 -LRB104 08649 BDA 18702 b HB2462 - 4 - LRB104 08649 BDA 18702 b
HB2462 - 4 - LRB104 08649 BDA 18702 b
1 faith is experiencing anaphylaxis, regardless of whether
2 the individual has a prescription for an epinephrine
3 injector or has previously been diagnosed with an allergy.
4 (d) An employee, agent, or other individual authorized
5 must complete an anaphylaxis training program before he or she
6 is able to provide or administer an epinephrine injector under
7 this Section. Such training shall be valid for a period of 2
8 years and shall be conducted by a nationally recognized
9 organization experienced in training laypersons in emergency
10 health treatment. The Department shall include links to
11 training providers' websites on its website.
12 Training shall include, but is not limited to:
13 (1) how to recognize signs and symptoms of an allergic
14 reaction, including anaphylaxis;
15 (2) how to administer an epinephrine injector; and
16 (3) a test demonstrating competency of the knowledge
17 required to recognize anaphylaxis and administer an
18 epinephrine injector.
19 Training may also include, but is not limited to:
20 (A) a review of high-risk areas on the authorized
21 entity's property and its related facilities;
22 (B) steps to take to prevent exposure to allergens;
23 (C) emergency follow-up procedures; and
24 (D) other criteria as determined in rules adopted
25 pursuant to this Act.
26 Training may be conducted either online or in person. The
HB2462 - 4 - LRB104 08649 BDA 18702 b
HB2462- 5 -LRB104 08649 BDA 18702 b HB2462 - 5 - LRB104 08649 BDA 18702 b
HB2462 - 5 - LRB104 08649 BDA 18702 b
1 entity or individual conducting the training shall issue a
2 certificate to each person who successfully completes the
3 anaphylaxis training program. The Department shall approve
4 training programs and list permitted training programs on the
5 Department's Internet website.
6 (Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.)
7 (410 ILCS 27/25 new)
8 Sec. 25. Good Samaritan protections. Any act or omission
9 taken in good faith pursuant to this Act by any of the
10 following entities or individuals shall be considered
11 emergency care, advice, or assistance under the Good Samaritan
12 Act: (i) an authorized entity that possesses and makes
13 available epinephrine injectors and its employees or agents;
14 (ii) an authorized individual who possesses, makes available,
15 and administers epinephrine injectors; (iii) a pharmacy or
16 manufacturer that dispenses epinephrine injectors to an
17 authorized entity or authorized individual; or (iv) an
18 individual or entity that conducts the training described in
19 subsection (d) of Section 10 of this Act.
20 Section 10. The Good Samaritan Act is amended by adding
21 Section 66 as follows:
22 (745 ILCS 49/66 new)
23 Sec. 66. Provision and administration of epinephrine
HB2462 - 5 - LRB104 08649 BDA 18702 b
HB2462- 6 -LRB104 08649 BDA 18702 b HB2462 - 6 - LRB104 08649 BDA 18702 b
HB2462 - 6 - LRB104 08649 BDA 18702 b
HB2462 - 6 - LRB104 08649 BDA 18702 b